Haifeng Lu Selected Research

Therapeutics

11/2021	Redox-Responsive Molecularly Imprinted Nanoparticles for Targeted Intracellular Delivery of Protein toward Cancer Therapy.
7/2014	An analysis of microbiota-targeted therapies in patients with avian influenza virus subtype H7N9 infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Haifeng Lu Research Topics

Disease

6	Infections 01/2022 - 04/2013
4	COVID-19 01/2021 - 10/2020
4	Chronic Hepatitis B 01/2020 - 04/2011
3	Neoplasms (Cancer) 11/2021 - 01/2020
3	Dysbiosis 09/2021 - 01/2016
3	Fibrosis (Cirrhosis) 01/2016 - 04/2011
2	Hyperalgesia 01/2022 - 01/2021
2	Neuralgia (Stump Neuralgia) 01/2022 - 01/2021
2	Hepatitis B 01/2022 - 12/2011
2	Pain (Aches) 01/2022 - 01/2021
2	Pneumonia (Pneumonitis) 01/2021 - 07/2014
2	Bipolar Disorder (Manic Depressive Psychosis) 07/2019 - 01/2019
2	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 02/2013
2	Coinfection 01/2016 - 07/2014
2	Bacteremia 10/2014 - 07/2014
1	Rheumatoid Arthritis 09/2021
1	Arthritis (Polyarthritis) 09/2021
1	Cognitive Dysfunction 01/2021
1	Stroke (Strokes) 01/2021
1	Headache (Headaches) 01/2021
1	Migraine Disorders (Migraine) 01/2021
1	Human Influenza (Influenza) 12/2020
1	Periodontitis 11/2020
1	Hypertension (High Blood Pressure) 10/2020
1	Critical Illness (Critically Ill) 10/2020
1	Calculi (Calculus) 03/2020
1	Gallstones (Gallstone) 03/2020
1	Pancreatitis 01/2020
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2020
1	Ischemia 01/2020
1	Poisoning 01/2018
1	Botulism 01/2018
1	Aphasia (Dysphasia) 08/2017
1	Ascites 01/2017
1	Body Weight (Weight, Body) 01/2017
1	Clostridium Infections 01/2016
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2015

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2016
4	16S Ribosomal RNAIBA 12/2020 - 01/2016
4	Antiviral Agents (Antivirals)IBA 01/2020 - 02/2013
3	Proteins (Proteins, Gene)FDA Link 11/2021 - 01/2017
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2016
3	Hepatitis B e AntigensIBA 01/2020 - 01/2016
2	C-Reactive ProteinIBA 01/2021 - 07/2014
2	lactitolIBA 01/2021 - 02/2013
2	Virulence Factors (Pathogenicity Factors)IBA 01/2021 - 04/2011
2	RNA (Ribonucleic Acid)IBA 12/2020 - 11/2020
2	Bile Acids and Salts (Bile Acids)IBA 11/2020 - 03/2020
2	DNA (Deoxyribonucleic Acid)IBA 03/2020 - 04/2011
2	Quetiapine Fumarate (Seroquel)FDA Link 07/2019 - 01/2019
2	EndotoxinsIBA 10/2014 - 02/2013
1	Gabapentin (Neurontin)FDA LinkGeneric 01/2022
1	Purinergic P2X4 ReceptorsIBA 01/2022
1	gamma- hydroxy- gamma- ethyl- gamma- phenylbutyramide (HEPB)IBA 01/2022
1	Pancreatic Ribonuclease (Ribonuclease A)IBA 11/2021
1	Glutathione (Reduced Glutathione)IBA 11/2021
1	DisulfidesIBA 11/2021
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 11/2021
1	Silicon Dioxide (Silica)FDA LinkGeneric 11/2021
1	CytokinesIBA 09/2021
1	MicroRNAs (MicroRNA)IBA 09/2021
1	Type II Tumor Necrosis Factor ReceptorsIBA 01/2021
1	Calcitonin Gene-Related PeptideIBA 01/2021
1	Botulinum Toxins (Botulinum Toxin)IBA 01/2021
1	Type I Tumor Necrosis Factor ReceptorsIBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	LipidsIBA 01/2021
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 10/2020
1	Blood Glucose (Blood Sugar)IBA 10/2020
1	CholesterolIBA 03/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Oxygen (Dioxygen)IBA 01/2020
1	ThrombospondinsIBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Interleukin-12 (IL 12)IBA 01/2020
1	DisintegrinsIBA 01/2020
1	Metalloproteases (Metalloproteinases)IBA 01/2020
1	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 01/2020
1	Hemostatics (Antihemorrhagics)IBA 11/2019
1	entecavir FDA Link 11/2019
1	Colistin (Coly-Mycin)FDA Link 06/2018
1	Carbapenems (Carbapenem Antibiotics)IBA 06/2018
1	Type A Botulinum Toxins (Botox)FDA Link 01/2018
1	incobotulinumtoxinA FDA Link 01/2018
1	GlobulinsIBA 01/2017
1	AlbuminsIBA 01/2017
1	Tenofovir (Viread)FDA Link 01/2016
1	alpha-beta T-Cell Antigen Receptors (T-Cell Receptor alpha-Chain)IBA 01/2016
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 03/2015
1	GalactosamineIBA 01/2015
1	LipopolysaccharidesIBA 01/2015
1	Secretory Immunoglobulin A (SIgA)IBA 10/2014

Therapy/Procedure

2	Therapeutics 11/2021 - 07/2014
2	Transcranial Magnetic Stimulation 01/2021 - 08/2017
1	Thrombolytic Therapy 10/2020
1	Drug Therapy (Chemotherapy) 01/2020
1	Injections 01/2018
1	Transplantation 01/2016